Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.81% |
| 2 | Technology | 2.36% |
| 3 | Consumer Discretionary | 1.65% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
3651
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.58M | ﹤0.01% |
70,045
-54,051
| -44% | -$3.4M |
|
|
CBAY
3652
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $4.58M | ﹤0.01% |
307,000
+292,500
| +2,017% | +$3.88M |
|
3653
CALL
Alcon
ALC
$34.8B
| $4.58M | ﹤0.01% |
59,400
-54,300
| -48% | -$4.46M |
|
3654
Newell Brands
NWL
$2.63B
| $4.58M | ﹤0.01% |
506,811
-441,606
| -47% | -$4.4M |
|
3655
CALL
International Seaways
INSW
$4.89B
| $4.58M | ﹤0.01% |
101,700
+15,300
| +18% | +$642K |
|
3656
CALL
Wyndham Hotels & Resorts
WH
$5.64B
| $4.58M | ﹤0.01% |
65,800
-31,200
| -32% | -$2.31M |
|
3657
CALL
FS KKR Capital
FSK
$3.39B
| $4.57M | ﹤0.01% |
232,300
-6,900
| -3% | -$138K |
|
3658
CALL
ProShares UltraShort Russell2000
TWM
$45.2M
| $4.57M | ﹤0.01% |
58,600
+260
| +0.4% | +$18.2K |
|
3659
PUT
California Resources
CRC
$4.64B
| $4.57M | ﹤0.01% |
81,600
+42,000
| +106% | +$2.24M |
|
3660
CALL
POSCO
PKX
$18.2B
| $4.56M | ﹤0.01% |
44,500
+36,800
| +478% | +$3.84M |
|
3661
PUT
Corteva
CTVA
$56B
| $4.56M | ﹤0.01% |
89,100
+37,800
| +74% | +$2M |
|
3662
Eos Energy Enterprises
EOSE
$1.19B
| $4.56M | ﹤0.01% |
2,119,085
-1,441,213
| -40% | -$4.31M |
|
3663
PUT
Viking Therapeutics
VKTX
$3.75B
| $4.55M | ﹤0.01% |
411,400
-166,500
| -29% | -$2.38M |
|
|
DEN
3664
DELISTED
Denbury Inc.
DEN
| $4.54M | ﹤0.01% |
46,357
-65,877
| -59% | -$5.96M |
|
3665
PUT
ACM Research
ACMR
$5.18B
| $4.54M | ﹤0.01% |
250,800
+182,100
| +265% | +$2.71M |
|
|
GMS
3666
CALL
DELISTED
GMS Inc
GMS
| $4.54M | ﹤0.01% |
71,000
-214,600
| -75% | -$14.9M |
|
3667
iShares Micro-Cap ETF
IWC
$1.5B
| $4.54M | ﹤0.01% |
45,367
-755
| -2% | -$81.6K |
|
3668
PUT
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.4B
| $4.54M | ﹤0.01% |
183,600
-9,400
| -5% | -$254K |
|
3669
CALL
Acadia Pharmaceuticals
ACAD
$5.02B
| $4.54M | ﹤0.01% |
217,700
+118,600
| +120% | +$3.22M |
|
3670
Ultragenyx Pharmaceutical
RARE
$2.52B
| $4.53M | ﹤0.01% |
127,057
+16,393
| +15% | +$650K |
|
3671
Capital Group International Focus Equity ETF
CGXU
$6.65B
| $4.53M | ﹤0.01% |
+208,308
| New | +$4.79M |
|
3672
CALL
ProShares UltraPro Short Russell2000
SRTY
$72.9M
| $4.53M | ﹤0.01% |
23,875
-4,175
| -15% | -$674K |
|
3673
Camden Property Trust
CPT
$12.3B
| $4.53M | ﹤0.01% |
47,857
+4,186
| +10% | +$445K |
|
3674
Toll Brothers
TOL
$13.5B
| $4.52M | ﹤0.01% |
61,177
-41,061
| -40% | -$3.24M |
|
3675
PUT
Urban Outfitters
URBN
$6.94B
| $4.52M | ﹤0.01% |
138,300
-154,400
| -53% | -$5.28M |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.